Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2008
10/02/2008WO2008118592A2 Use of an avirulent bordetella mutant as a live vaccine vector
10/02/2008WO2008116368A1 A method for preparing antigens of foot-and-mouth disease virus
10/02/2008WO2008088410A3 Influencing viral lipid constituents
10/02/2008WO2008078056A3 Method for amplifying hcv in aedes mosquitoes
10/02/2008WO2008021140A3 Recombinant aav production in mammalian cells
10/02/2008US20080242610 Anticarcinogenic agents; polypeptide including ligand that stimulants natural killer receptor and intracytoplasmic death domain
10/02/2008US20080242552 Molecular recognition of materials
10/02/2008US20080241930 Paramyxoviridae Virus Preparations
10/02/2008US20080241929 Method and means for producing high titer, safe, recombinant lentivirus vectors
10/02/2008US20080241906 Shifting elution properties of viral protein in order to enhanced purification from solution
10/02/2008US20080241905 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine
10/02/2008US20080241531 Viral fibers
10/02/2008US20080241244 Combining with such as potassium phosphate buffer solution containing sucrose, gelatin and ethylene oxide-propylene oxide copolymer; cooling, expanding then evaporation or sublimation drying; shelf life
10/02/2008US20080241187 Stabilization of viral compositions
10/02/2008US20080241185 A matrix of a crosslinked polyampholyte having a cavity capable of selectively binding to a template of microorganisms, bacteria, proteins, nucleic acids; cartridges for blood dialysis (HIV); purification by washing a chromatography column loaded with a cell/tissue extracted virus followed by elution
10/02/2008US20080241103 Recombinant Virus Comprising an Intact Tumor-Therapeutic Antibody With Human Constant Regions and the Use Thereof
10/02/2008CA2685497A1 Imprinted polymeric materials for binding various targets such as viruses
10/02/2008CA2678698A1 Use of an avirulent bordetella mutant as a live vaccine vector
10/01/2008EP1975235A2 Porcine circovirus vaccine in recombinant poxvirus
10/01/2008EP1974744A1 Immunization through oral administration of a vaccine with an edible product
10/01/2008EP1974023A1 Dengue chimeric viruses
10/01/2008EP1973931A2 Chicken virus vaccine and diagnostic
10/01/2008EP1973566A1 An adjuvant system comprising virosomes and liposomes
10/01/2008EP1285080B1 Method for the purification of alphavirus replicon particles
10/01/2008EP0766512B1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
10/01/2008CN101278043A Chimeric empty viral-like particles derived from the infectious bursal disease virus (IDBV), process for their production and applications
10/01/2008CN101278042A Novel recombinant human hepatitis c virus-like particle and method for producing the same
10/01/2008CN101275142A Newcastle disease virus infectious clones, vaccines and diagnostic assays
10/01/2008CN101275122A Fast screen method for recombinant baculovirus
10/01/2008CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
09/2008
09/30/2008US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease
09/30/2008US7429643 POSH nucleic acids, polypeptides and related methods
09/30/2008US7429485 Method of producing infectious reovirus
09/30/2008CA2328084C Viral production process
09/30/2008CA2264953C Modifying insect cell gylcosylation pathways with baculovirus expression vectors
09/30/2008CA2261989C Recombinant pox virus for immunization against tumor-associated antigens
09/25/2008WO2008115296A2 Modified phage for displaying post-translationally modified proteins and uses thereof
09/25/2008WO2008098239A3 Paramyxovirus family inhibitors and methods of use thereof
09/25/2008WO2008026225A3 A vaccine for chikungunya virus infection
09/25/2008US20080235816 Multiple inducible gene regulation system
09/25/2008US20080234220 Reducing flavivirus or Hepatitis virus replication in vitro or vivo by inhibiting activity of a microRNA; administering an antisense oligonucleotide complementary to microR-122
09/25/2008US20080233602 Detecting and profiling molecular complexes
09/25/2008US20080233560 DNA-transfection system for the generation of infectious influenza virus
09/25/2008US20080233148 Method of Producing Virus
09/25/2008US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD)
09/25/2008US20080233146 Promoter gene, recombinant turkey herpesvirus having the novel promoter gene, and poultry vaccine including the recombinant herpes virus of turkey
09/25/2008US20080233141 Chimera of papillomavirus capsid polypeptide L2; cervical cancers and warts; capsomeres
09/25/2008US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology
09/24/2008EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis
09/24/2008CN101270350A Method for extracting rabies virus
09/24/2008CN100420742C Oncolytic adenovirus with target for liver cancer and its preparation method and use
09/23/2008US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
09/23/2008CA2163256C Adenoviral vectors of animal origin and use thereof in gene therapy
09/18/2008WO2008113011A2 Virus like particle purification
09/18/2008WO2008110579A2 Adenovirus with mutations in the endoplasmic reticulum retention domain of the e3-19k protein and their use in cancer treatment.
09/18/2008WO2008110056A1 A vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof
09/18/2008WO2008110004A1 Reoviruses having modified sequences
09/18/2008US20080227774 5,5-disubstituted-indolizinone compounds
09/18/2008US20080227688 Inhibition of viral replication
09/18/2008US20080227146 Immortalized Avian Cell Lines For Virus Production
09/18/2008US20080227127 Human NK3-Related Prostate Specific Gene-1
09/18/2008US20080226677 Recombinant virus vector for gene transfer into lymphoid cells
09/18/2008US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome
09/18/2008US20080226664 Colon cancer antigen panel
09/18/2008US20080226660 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders
09/18/2008US20080226602 RNA viral vector for use in targeting tumor cell for destruction; antitumor agents and gene therapy
09/18/2008US20080226600 Adeno-associated viruses and uses thereof
09/18/2008US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines
09/18/2008US20080226594 Culturing circular ssdna viruses for the production of vaccines
09/18/2008CA2680659A1 Adenovirus with mutations in the endoplasmic reticulum retention domain of the e3-19k protein and their use in cancer treatment
09/18/2008CA2678721A1 Reoviruses having modified sequences
09/17/2008EP1970449A1 Attenuated salmonella SPI2 mutants as antigen carriers
09/17/2008EP1194564B1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines
09/17/2008EP1157098B1 Apparatus and methods for producing and using high-density cells and products therefrom
09/17/2008CN101267834A 白介素-1偶联物及其用途 Interleukin-1 conjugates and their use
09/16/2008US7425443 Treatment of diabetes with synthetic beta cells
09/16/2008US7425437 Human cells comprising sequence encoding early region-1 (E1) gene product of an adenovirus; cultured in suspension to very high densities under serum-free conditions
09/16/2008US7425337 Alphavirus replicon vector systems
09/16/2008CA2445358C Cells for detection of enteroviruses
09/12/2008WO2008109721A1 Chromatographic methods for assessing adenovirus purity
09/12/2008WO2008109686A2 Non- infectious recombinant virus-like particles and their pharmaceutical applications
09/12/2008WO2008109398A1 T4 bacteriophage bound to a substrate
09/12/2008WO2008108989A2 Cultures with improved phage resistance
09/12/2008WO2008108344A1 Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell
09/12/2008WO2008089569A9 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
09/12/2008WO2008039357A3 Uncoupling of dna insert propagation and expression of protein for phage display
09/12/2008WO2007130327A3 Influenza virus-like particle (vlp) compositions
09/12/2008CA2680129A1 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
09/12/2008CA2679765A1 T4 bacteriophage bound to a substrate
09/11/2008US20080221058 Tumor-Specific Vector for Gene Therapy
09/11/2008US20080220508 Bacteriophages that infect bacillus bacteria (anthrax)
09/11/2008US20080220410 Method for replicating the hepatitis c virus
09/11/2008US20080220409 Lymphocyte epitope for use as evaluative tool in diagnosis of flaviviral infection
09/11/2008US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering
09/11/2008US20080220017 administering modified virus particles having reduced lipid content, drugs carriers and immunostimulants, to provide protection against infection by viral diseases
09/11/2008US20080220016 Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties
09/11/2008US20080220014 Recombinant viral-based malaria vaccines
09/11/2008US20080219999 Immunoadhesin for the prevention of rhinovirus infection
09/11/2008US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells
09/10/2008EP1967590A2 Lentiviral packaging constructs